Contact
Please use this form to send email to PR contact of this press release:
Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T
TO:
Please use this form to send email to PR contact of this press release:
Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T
TO: